Jay Cross

Jay Cross

Director of Finance/CFO at
Senti Biosciences, Inc.

Net worth: - $ as of 31/05/2026

55 year
Health Technology
Consumer Services
Finance

Profile

John Harry Cross is currently Chief Financial Officer at Senti Biosciences Holdings, Inc. since 2026 and Chief Financial Officer at Senti Biosciences, Inc. since 2025.
Formerly, Mr. Cross was Chief Financial Officer, Treasurer & Secretary at Sonnet BioTherapeutics Holdings, Inc. from 2019 to 2025, Managing Director-Healthcare Investment Banking at Chardan Capital Markets LLC from 2015 to 2019, Director at Alere Financial Partners from 2014 to 2015, and Chief Financial & Business Officer at Sonnet BioTherapeutics, Inc. Education includes undergraduate studies at Washington & Lee University and graduate studies at Yale School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
-.--%
27/03/2026 0 ( -.--% ) - $ 31/05/2026

Jay Cross active positions

CompaniesPositionStart
Director of Finance/CFO 03/03/2025

Former positions of Jay Cross

CompaniesPositionEnd
SONNET BIOTHERAPEUTICS Director of Finance/CFO 21/02/2025
Corporate Officer/Principal 01/03/2019
Director/Board Member 01/06/2015
Director of Finance/CFO -
See the detail of Jay Cross's experience

Training of Jay Cross

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

7

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Finance

Finance

Consumer Services

Health Technology

Health Technology

Health Technology